Renin-Angiotensin System Inhibitors Prognostic Benefit in Older Patients with Atrial Fibrillation
Angiotensin-converting enzyme inhibitors (ACEi) and angiotensin-receptor blockers (ARB) have shown antiarrhythmic effects that are useful as part of the upstream therapy for atrial fibrillation (AF), both for primary and secondary prevention. Nevertheless, the potential prognosis value of these drug...
Saved in:
Published in | Journal of the American Medical Directors Association |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.10.2021
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Be the first to leave a comment!